MPAL — Medpal AI Share Price
Last trade - 00:00- £35.63m
- £35.52m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Aug | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MedPal AI plc is a United Kingdom-based digital health company specializing in artificial intelligence (AI)-driven wellness management. Its app aggregates data from over 100 wearables and health applications, such as Apple Health, Fitbit, Garmin into a unified profile, offering non-clinical, personalized lifestyle guidance through its AI wellness coach. It helps users proactively manage their well-being by detecting health patterns, providing actionable recommendations, and offering intelligent alerts bridging the gap between raw data and practical guidance. The Company is also developing conversational AI to provide voice-based, real-time health insights, alerts, and recommendations. It also holds the NHS Pharmacy Contract, the United Kingdom Distance Selling Pharmacy (DSP) license, enabling regulated online and mail-order pharmaceutical services.
Directors
- Last Annual
- August 31st, 2024
- Last Interim
- February 28th, 2025
- Incorporated
- August 23rd, 2021
- Public Since
- August 26th, 2025
- No. of Employees
- 1
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- London Stock Exchange
- Shares in Issue
- 413,083,335
- Address
- Hill Dickinson Llp, LONDON, EC2A 2EW
- Web
- https://www.medpalplc.com/
- Phone
- Auditors
- RPG Crouch Chapman LLP
Similar to MPAL
1Spatial
London Stock Exchange
accesso Technology
London Stock Exchange
Activeops
London Stock Exchange
Acuity RM
London Stock Exchange
AdvancedAdvT
London Stock Exchange
FAQ
As of Today at 21:58 UTC, shares in Medpal AI are trading at 8.63p. This share price information is delayed by 15 minutes.
Shares in Medpal AI last closed at 8.63p and the price had moved by over the past 365 days. In terms of relative price strength the Medpal AI share price has matched the FTSE All Share Index by over the past year.
There is no consensus recommendation for this security.
Find out moreMedpal AI does not currently pay a dividend.
Medpal AI does not currently pay a dividend.
Medpal AI does not currently pay a dividend.
To buy shares in Medpal AI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 8.63p, shares in Medpal AI had a market capitalisation of £35.63m.
Here are the trading details for Medpal AI:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MPAL
Based on an overall assessment of its quality, value and momentum Medpal AI is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medpal AI. Over the past six months, its share price has matched the FTSE All Share Index by .
As of the last closing price of 8.63p, shares in Medpal AI were trading -5.36% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medpal AI PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 8.63p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Medpal AI's directors